Search

everythinglearnresearchcommunity

for

Search:↓

SFRP2 and PTGDS may be key factors in female hair loss.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Sansevieria trifasciata Prain shows promise for treating hair loss by inhibiting androgen receptors.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Androgens can both increase and decrease hair growth in different parts of the body.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The HR protein's role as a repressor is essential for controlling hair growth.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

No cure for female pattern hair loss, but various effective treatments exist.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.